Header cover image

Japanese Pharmaceuticals & Biotech Your first investment

Results

10

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

10 companies

Chugai Pharmaceutical

Market Cap: JP¥11.8t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥7,175.00

7D

6.1%

1Y

17.0%

Otsuka Holdings

Market Cap: JP¥6.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥12,435.00

7D

2.2%

1Y

58.3%

Daiichi Sankyo Company

Market Cap: JP¥5.0t

Manufactures and sells pharmaceutical products in Japan and internationally.

4568

JP¥2,770.00

7D

4.1%

1Y

-22.4%

Astellas Pharma

Market Cap: JP¥4.2t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,327.50

7D

1.7%

1Y

40.9%

Shionogi

Market Cap: JP¥2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

4507

JP¥2,819.00

7D

-0.2%

1Y

6.8%

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

4151

JP¥2,612.50

7D

3.9%

1Y

-0.7%

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

4528

JP¥2,417.50

7D

3.4%

1Y

40.0%

Santen Pharmaceutical

Market Cap: JP¥630.8b

Engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

4536

JP¥1,964.00

7D

4.7%

1Y

27.4%

Tsumura

Market Cap: JP¥279.0b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

4540

JP¥3,743.00

7D

-0.5%

1Y

4.9%

Nippon Shinyaku

Market Cap: JP¥243.5b

Manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally.

4516

JP¥3,613.00

7D

2.1%

1Y

10.6%